Press release
Rapid Growth Discoveries in the Biopharmaceutical CMO Market amid Increasing Demand and Notable Trends
Rapid Growth Discoveries in the Biopharmaceutical CMO Market Size
Unlocking Multifaceted Insights on the Impressive Expansion of the Global Biopharmaceutical CMO Market
What Is The Projected Market Size Of The Global Biopharmaceutical CMO Market And Its Growth Rate?
• The biopharmaceutical CMO market has grown rapidly in recent years, expanding from $24.81 billion in 2024 to $28.09 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.2%.
• The growth in the historical period can be attributed to increasing demand for biopharmaceuticals, globalization, rise in healthcare expenditure, regulatory support, and increased research funding.
• The biopharmaceutical CMO market size is expected to see rapid growth in the next few years, growing to $48.04 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%.
• The growth can be attributed to rise in telehealth and remote trials, global health initiatives, rise in disposable income, and global health initiatives.
What Is Driving The Growth In The Biopharmaceutical CMO Market?
The growth of the biopharmaceutical CMO market is largely propelled by an increase in the geriatric population. Aging individuals are more susceptible to serious conditions such as heart attack, stroke, coronary heart disease, and heart failure, thus underpinning demand for biopharmaceutical therapies that target age-related diseases. The growth in the geriatric population, driven by advances in healthcare, declining birth rates, and the aging of the baby boomer generation, is augmenting demand for specialized manufacturing capabilities for complex biologics and personalized medicines, offered by biopharmaceutical CMOs. For example, the Population Reference Bureau reported that the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050.
Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=7771&type=smp
Who Are the Key Players Driving Biopharmaceutical CMO Market Growth?
• Lonza Group AG
• Fujifilm Diosynth Biotechnologies USA Inc.
• Thermo Fisher Scientific Inc.
• Samsung Biologics
• WuXi AppTec
• Catalent, Inc.
• Rentschler Biopharma SE
• Boehringer Ingelheim
• Recipharm AB
• Other notable players
What Are The Key Trends In The Biopharmaceutical CMO Market?
• Dominance of advanced therapies
• Digitalization and industry 4.0
• Continuous manufacturing
• Sustainability and green practices
What Are The Segments Of The Global Biopharmaceutical CMO Market?
• By Product: Biologics, Biosimilars
• By Source: Mammalian, Non-Mammalian
• By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging
Which Region Leads The Biopharmaceutical CMO Market?
North America was the largest region in the biopharmaceutical CMO market in 2024, while Asia-Pacific is expected to witness the fastest growth in the forecast period. The biopharmaceutical CMO industry spreads across Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery: https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report
What Is Covered In The Biopharmaceutical CMO Market Global Market Report?
- Market Size Analysis: Analyze the Biopharmaceutical CMO Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Biopharmaceutical CMO Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Biopharmaceutical CMO Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Biopharmaceutical CMO Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report: https://www.thebusinessresearchcompany.com/Customise?id=7771&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
"Learn More About The Business Research Company
With over 15,000+ reports covering 27 industries across 60+ geographies, The Business Research Company provides comprehensive, data-rich research and insights. With 1,500,000 datasets, we contribute in-depth secondary research and unique insights from industry leaders to provide the information you need to stay ahead. Our flagship product, the Global Market Model, is a leading market intelligence platform providing comprehensive and up-to-date forecasts to support informed decision-making."
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rapid Growth Discoveries in the Biopharmaceutical CMO Market amid Increasing Demand and Notable Trends here
News-ID: 3812288 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for CMO
Healthcare Cmo Market Size Analysis by Application, Type, and Region: Forecast t …
USA, New Jersey- According to Market Research Intellect, the global Healthcare Cmo market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The healthcare contract manufacturing organization (CMO) market is witnessing steady expansion due to increasing demand for outsourced pharmaceutical and medical device production. Rising healthcare costs…
New Fractional CMO Agency Offers Fractional CMO Services to Businesses of All Si …
Modern CMO, a new fractional CMO agency, has officially launched to offer businesses of all sizes access to expert-level marketing strategies and a team of experienced CMOs to lead their marketing initiatives.
Modern CMO's fractional CMO services provide businesses with access to the same level of expertise as a full-time CMO, without the costly overhead expenses. This means that businesses can tap into Modern CMO's pool of highly skilled marketing professionals…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Healthcare CMO Market
Healthcare CMO Market to 2027 - Global Analysis and Forecasts By Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services), and Geography
The global healthcare CMO market is expected to witness substantial growth. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…
